ATOS - Atossa Genetics Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue---1.758
Cost of Revenue---132.411
Gross Profit----130.653
Operating Expenses
Research Development-2,328.087770.4272,359.593
Selling General and Administrative-4,859.3696,479.19310,268.372
Non Recurring----
Total Operating Expenses-7,187.4567,249.6212,760.376
Operating Income or Loss--7,187.456-7,249.62-12,758.618
Income from Continuing Operations
Total Other Income/Expenses Net--935.125880.7350.431
Earnings Before Interest and Taxes--7,187.456-7,249.62-12,758.618
Interest Expense----
Income Before Tax--8,122.581-6,368.885-12,758.187
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops--8,122.581-6,368.885-12,758.187
Non-recurring Events
Discontinued Operations----3,002.136
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income--8,122.581-6,368.885-15,760.323
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares--10,690.713-6,368.885-15,760.323